search news
press releases
background
act!
links
archive
home

Immediate ratification of Biosafety Protocol needed


The Hague, the Netherlands 23 April 2002 – Government representatives from around the world are meeting 22-26 April in the Hague (Netherlands) at the third Intergovernmental Committee on the UN Cartagena Protocol on Biosafety (ICCP-3) to elaborate safety rules for handling and trading genetically modified organisms (GMOs). The discussions take place at a crucial time; the first case of genetic contamination by GMOs of a centre of diversity must be addressed, and a number of countries are deciding on their regulations concerning labelling, traceability and imports of  GMOs.

Greenpeace supports the Biosafety Protocol and calls for:

  • Immediate ratification of the Biosafety Protocol
  • Establishment of an effective liability regime that covers all aspects of the Biosafety Protocol; this regime should be implemented as soon as possible after the Protocol’s entry into force;
  • Immediate enactment of special measures to protect centres of genetic diversity/origin and other environmentally sensitive areas from being contaminated by GMOs
  • Each transport of an LMO to be accompanied with precise information on the GMOs that are carried. The producer of the GMO must provide an internationally standardised Unique Identifier with each transport, and information that enables the identification and standardised testing of GMOs.
  • The Biosafety Clearinghouse to be provided with all available information regarding the GMOs (i.e. taxonomic and genetic nature, intended use, risk assessment, monitoring results, approval information, scientific findings). The Biosafety Clearinghouse must be notified of all transboundary movements of GMOs, including unintended spread, and presence in products or in the environment.
  • The Biosafety Clearinghouse to provide equal access to its information to all parties involved.
  • Capacity building initiatives to urgently be directed at enabling immediate and practical means of identification and regulation of GMO imports in all signatory states, especially in developing countries. Capacity for risk assessment in the varied environmental conditions of the countries of import should be considered as a high priority.


Further reading:

top/back